Beyond Start-Up Nation: Israel's Growth Platform for Global Co-Innovation

Strategic Shift from "Startup Nation" to Scale-Up

• Israel is transitioning from a "Startup Nation" model, defined by R&D creation and rapid exits, to a "Beyond Startup Nation" model focused on scaling companies locally and building sustainable industrial bases.
• The Office of the Chief Scientist historically drove growth by building a high-tech labor force representing 10% of the workforce, generating over 50% of industrial exports and approximately 38% of foreign exchange reserves.
• The primary goal is to move beyond the "exit nation" trap (selling to M&A) toward creating mid-tier companies with the runway to become large-scale global enterprises.
• Yossi Beinart, CEO of the Tel Aviv Stock Exchange (TASE), identifies a critical market failure: the lack of capital for mid-tier companies (valued $50M–$500M) forces premature exits, resulting in only one Israeli company on the Forbes 500 list (Teva) compared to eight in Sweden and 16 in Switzerland.
• The average exit value in Israel has surged from $30 million in 2008 to over $200 million in the most recent year, signaling a maturation of deal sizes despite the lack of homegrown giants.
• 2014 saw $3.4 billion invested in Israeli high-tech, a 46% year-over-year increase, occurring despite 50 days of missile attacks and airport shutdowns.
• Exit values reached approximately $15 billion last year, with 10 nominally billion-dollar exits occurring in just the last two years, matching the total count of such exits from the prior decade.
• Serial entrepreneurs are now a dominant force, with founders of companies like Check Point, Waze, and Amazon's Annapurna driving a new wave of patient, long-term company building.
• Private equity and growth equity firms (KKR, TPG, Carlyle, Silver Lake) are entering the Israeli market, providing a third option for companies beyond IPOs or M&A, addressing the "funding gap" for scaling.

Capital Markets and Financial Infrastructure Evolution

• Israel has shifted from a developing to a developed economy status, yet remains an outlier with only 14-15% of GDP coming from industry, heavily skewed toward services compared to the OECD average.
• Over the last 10 years, over $50 billion in merchandise was sold via M&A, often driven by the inability of the local capital market to fund mid-tier growth.
• The Tel Aviv Stock Exchange is implementing structural reforms to create financial products (e.g., BDCs) and foster an environment where companies can grow independently of immediate exits.
• The "second generation" of entrepreneurs—those who previously exited successfully—are now returning to the market with a longer-term horizon and patience for scaling.
• John Medved notes that the local market is isolated to early R&D stages, necessitating a strategic reboot to extend the value chain and retain value creation within Israel.

Crowdfunding and Global Capital Access

• OurCrowd has become the world's largest equity crowdfunding platform, leveraging a model that bridges angel investing and venture capital for accredited investors.
• The platform allows individual investors to access Israeli startups for a minimum of $10,000, with 80% of investments targeted in Israel.
• OurCrowd has facilitated $120 million in investments to date, sourcing 120 million in the current year goal, funded by 8,000 individual investors from 110 countries rather than institutional funding.
• The platform curates over 2,000 deals annually, performing due diligence and investing its own capital before inviting the crowd to co-invest.
• This model addresses the barrier to entry for non-institutional investors who wish to participate in Israel's high-tech growth story.

Health Co-Innovation and Translational Medicine

• Dr. Nora Yang (NIH) identifies a "valley of death" in biomedical innovation where only 5% of projects succeed, driven by a funding mismatch: $22–23 billion for basic research, $7–8 billion for translational development, and $125 billion for commercialization.
• The translational gap is characterized by underfunded development phases where costs rise exponentially (millions to tens of millions to hundreds of millions) while venture capital availability drops.
• New financing models proposed by NCATS and MIT involve portfolio-based approaches mixing equity, senior debt, and mezzanine financing to achieve 14-15% returns on equity for investors.
• A "third-party guarantee" structure is being tested to de-risk translational projects and allow the funding of 9–16 projects within a single portfolio.
• The U.S. JOBS Act provision allowing confidential filing until funding is raised has reportedly caused a dramatic increase in IPO activity in the pharmaceutical sector by protecting proprietary formulas.
• Bioengineering foundries and convergent science platforms are being explored to apply technologies across multiple sectors, including food, biofuels, and disease treatment (e.g., malaria).

Water Security and Infrastructure Partnerships

• California and Israel are leveraging their shared expertise in desalination and water scarcity to address global water challenges, noting that 56% of global hospital beds are filled with waterborne disease victims.
• California faces complex water policy fragmentation with hundreds of agencies compared to Israel's centralized authority, leading to permitting delays of up to eight years for projects like the Carlsbad desalination plant versus 1–2 years in Israel.
• Approximately 700 of California's 2,600 community water systems rely on contaminated groundwater, representing a significant market for Israeli decentralized and mobile water treatment technologies.
• The "water-energy nexus" is a critical investment area; reducing water usage in California simultaneously lowers energy consumption and carbon emissions.
• Israel's drip irrigation technology and greywater reuse systems are identified as key technologies for California's 40% smallholder agricultural sector to increase productivity and water efficiency.
• Distributed water systems utilizing renewable energy (solar/wind) are proposed to serve off-grid communities, offering a scalable model for Africa and other regions.

Cybersecurity and IT Integration

• Cybersecurity is positioned as a mandatory component of all IT infrastructure, alongside big data, to protect the integrity of communication, data storage, and decision-making in sectors ranging from medicine to smart cities.
• The "point-wise" security model is being replaced by a multidisciplinary approach that separates compute and transmission functions to mitigate malicious intrusion.
• Specific risks include the potential for cyber intrusions into critical medical machinery (e.g., MRIs) and the need for robust data segregation in mobile and cloud environments.
• The integration of IT with water, energy, and health grids requires advanced cybersecurity to prevent systemic failures in smart networks and urban infrastructure.

Emerging Markets and Future Trajectory

• A historic economic inflection point occurred two years ago when the GDP of emerging and frontier markets (purchasing power parity) surpassed that of developed markets.
• Foreign investment in Israel is diversifying beyond the US and Europe, with a significant rise in capital from Asia, including Samsung (8 investments) and Li Ka-shing's Horizons Ventures (29 investments).
• Multinational corporations are deeply integrated into Israel's ecosystem; Cisco and EMC have acquired 13 and 12 companies respectively, with Intel increasing its investment by $6 billion for a 10-nanometer fab just weeks after a regional conflict.
• The "co-innovation" model relies on field schools and labs (e.g., in Be'er Sheva) to test solutions for global challenges, involving partners from California, India, China, and the US.
• Satellite imagery and remote sensing technologies are being deployed to monitor aquifer depletion, enabling better crop insurance and loan mechanisms for smallholder farmers in Africa.
• Sustainable Development Goals (SDGs) are expected to drive global growth, requiring the rapid deployment of these co-innovated solution sets in frontier markets.